Therapeutic opportunities for targeting cold pain pathways
Kathleen Yin(The University of Queensland), Richard J. Lewis(AstraZeneca (Netherlands)), Irina Vetter(Centre National de la Recherche Scientifique), Katharina Zimmermann(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 41
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
|Cancer Cell|2013|680
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654